Literature DB >> 10431846

Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation.

H C Blair1, S S Dong, B A Julian.   

Abstract

Mast cells accumulate in hyperparathyroid bone, but the reason is not clear. We compared the distribution of mast cells and related growth factors in normal and hyperparathyroid bone. Mast cell formation was strongly affected by proximity to bone-forming surfaces of hyperparathyroid bone. Hyperparathyroidism greatly increased the production by active, bone-synthesizing osteoblasts of stem cell factor (SCF) but not of IL-3. Osteoblast SCF was distributed to the basolateral cell membranes, and its cDNA sequence (GenBank AF119835) is homologous to the murine membrane-bound SCF. Quiescent osteoblasts did not produce detectable SCF. Synthetic osteoblasts in normal bone were SCF positive, but comprised a much smaller population of cells, in keeping with the slow turnover of normal bone. Major SCF isoforms on immunoblot analysis of osteoblast-fraction proteins from high-turnover bone had M(r)s of about 48 and 40 kDa. Similar SCF isoforms were produced by MG63 osteoblast-derived cells and were identified by several anti-SCF antibodies. SCF is expressed in several mesenchymal cell types in a complementary fashion with cells bearing its receptor. SCF potently facilitates differentiation of mast cells, so the increase in paratrabecular mast cells in hyperparathyroid bone is probably driven by osteoblastic SCF. However, since mast cells are not normal components of bone, osteoblastic SCF probably regulates other cells, with mast cell differentiation occurring as a side effect greatly increased osteoblastic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431846     DOI: 10.1007/s004280050394

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  8 in total

Review 1.  Cell biology of osteoimmunology.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2010-08-16

2.  Biology of umbilical cord blood progenitors in bone marrow niches.

Authors:  Mo A Dao; Michael H Creer; Jan A Nolta; Catherine M Verfaillie
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  Systemic mastocytosis with skeletal involvement: a case report and review of the literature.

Authors:  Maurizio Benucci; Catia Bettazzi; Stefania Bracci; Plinio Fabiani; Laura Monsacchi; Carlo Cappelletti; Mariangela Manfredi; Stefania Ciolli
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 4.  Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression.

Authors:  Sutada Lotinun; Jean D Sibonga; Russell T Turner
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

5.  Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation.

Authors:  Ying-Hua Cheng; R Adam Hooker; Khanh Nguyen; Rita Gerard-O'Riley; David L Waning; Brahmananda R Chitteti; Tomas E Meijome; Hui Lin Chua; Artur P Plett; Christie M Orschell; Edward F Srour; Lindsey D Mayo; Fredrick M Pavalko; Angela Bruzzaniti; Melissa A Kacena
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

6.  The role of mast cells in parathyroid bone disease.

Authors:  Russell T Turner; Urszula T Iwaniec; Kevin Marley; Jean D Sibonga
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

7.  Bone Marrow-Derived Stem Cell Factor Regulates Prostate Cancer-Induced Shifts in Pre-Metastatic Niche Composition.

Authors:  Brittni M Foster; Lihong Shi; Koran S Harris; Chirayu Patel; Victoria E Surratt; Kendall L Langsten; Bethany A Kerr
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

8.  Increased Bone Mass in Female Mice Lacking Mast Cell Chymase.

Authors:  Thomas Lind; Ann-Marie Gustafson; Gabriela Calounova; Lijuan Hu; Annica Rasmusson; Kenneth B Jonsson; Sara Wernersson; Magnus Åbrink; Göran Andersson; Sune Larsson; Håkan Melhus; Gunnar Pejler
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.